Clinical characteristics and outcome for treatment for borderline ovarian tumor in King Chulalongkorn Memorial Hospital

1. Classification and staging of malignant tumors in female pelvis (no authors listed). Acta Obstet Gynecol Scand. 1971; 50:1-7.10.3109/00016347109157278Search in Google Scholar

2. Acs G. Serous and mucinous borderline (low malignant potential) tumors of the ovary. Am J Clin Pathol. 2005; 123 (Suppl); s13-s57.10.1309/J6PXXK1HQJAEBVPMSearch in Google Scholar

3. Tinelli R, Tinelli A, Tinelli FG, Cicinelli E, Malvasi A. Conservative surgery for borderline ovarian tumors: a reviews. Gynecol Oncol. 2006; 100:185-91. Epub 2005 Oct 10.10.1016/j.ygyno.2005.09.021Open DOISearch in Google Scholar

4. Ozols RF, Rubin FC, Thomas GM. Epithelial ovarian cancer. In: Hoskins WJ, Perez CA, Young RC, editors. Principle and practice of gynecologic oncology, 4th ed. Philadelphia, Pennsylvania, USA: Lippincott Williams & Wilkins; 2005: p. 539-57.Search in Google Scholar

5. FIGO (International Federation of Gynecology and Obstetrics) annual report on the results of treatment in gynecological cancer. [No authors listed]. Int J Gynaecol Obstet. 2003; 83 Suppl 1:ix-xxii, 1-229.Search in Google Scholar

6. Hart WR, Norris HJ. Borderline and malignant mucinous tumors of the ovary. Histologic criteria and clinical behavior. Cancer. 1973; 31:1031-45.10.1002/1097-0142(197305)31:5<1031::AID-CNCR2820310501>3.0.CO;2-7Open DOISearch in Google Scholar

7. Bell DA. Ovarian surface epithelial-stromal tumors. Hum Pathol. 1991; 22:750-62.10.1016/0046-8177(91)90205-4Open DOISearch in Google Scholar

8. Ronnett BM, Kajdacsy-Balla A, Gilks CB, Merino MJ, Silva E, Werness BA, et al. Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior. Hum Pathol. 2004; 35:949-60.10.1016/j.humpath.2004.03.006Open DOISearch in Google Scholar

9. Bj rge T, Engeland A, Hansen S, Trope CG. Trends in the incidence of ovarian cancer and borderline tumours in Norway, 1954-1993. Int J Cancer. 1997; 71: 780-6.10.1002/(SICI)1097-0215(19970529)71:5<780::AID-IJC15>3.0.CO;2-CSearch in Google Scholar

10. Ayhan A, Guven S, Guven ES, Kucukali T. Is there a correlation between tumor marker panel and tumor size and histopathology in well staged patients with borderline ovarian tumors? Acta Obstet Gynecol Scand. 2007; 86:484-90.10.1080/00016340701226138Open DOISearch in Google Scholar

11. Trop_ C, Kaern J, Vergote IB, Kristensen G, Abeler V. Are borderline tumors of the ovary overtreated both surgically and systemically? A review of four prospective randomized trials including 253 patients with borderline tumors. Gynecol Oncol. 1993; 51: 236-43.10.1006/gyno.1993.1279Open DOISearch in Google Scholar

12. Morice P, Camatte S, Rey A, Atallah D, Lhomm_ C, Pautier P, et al. Prognostic factors for patients with advanced stage serous borderline tumours of the ovary. Ann Oncol. 2003; 14:592-8.10.1093/annonc/mdg173Open DOISearch in Google Scholar

13. Kayikcioglu F, Pato O, Cengiz S, Tulunay G, Boran N, Yalvac S, et al. Accuracy of frozen section diagnosis in borderline ovarian malignancy. Gynecol Obstet Invest. 2000; 49:187-9.10.1159/00001024410729760Open DOISearch in Google Scholar

14. Houck K, Nikrui N, Duska L, Chang Y, Fuller AF, Bell D, et al. Borderline tumors of the ovary: correlation of frozen and permanent histopathologic diagnosis. Obstet Gynecol. 2000; 95: 839-43.10.1097/00006250-200006000-00011Search in Google Scholar

15. Menzin AW, Rubin SC, Noumoff JS, LiVolsi VA. The accuracy of a frozen section diagnosis of borderline ovarian malignancy. Gynecol Oncol. 1995; 59:183-5.10.1006/gyno.1995.00047590469Open DOISearch in Google Scholar

16. Seidman JD, Kurman RJ. Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases. Am J Surg Pathol. 1996; 20: 1331-45.10.1097/00000478-199611000-000048898837Open DOISearch in Google Scholar

17. Cadron I, Leunen K, Van Gorp T, Amant F, Neven P, Vergote I. Management of borderline ovarian neoplasms. J Clin Oncol. 2007; 25:2928-37.10.1200/JCO.2007.10.807617617524Open DOISearch in Google Scholar

18. Cheng B, Wan X, Qian X, Lv W, Xie X. Results of conservative surgery for recurrent borderline ovarian tumors. Eur J Gynaecol Oncol. 2009; 30:75-8.Search in Google Scholar

19. Fauvet R, Poncelet C, Boccara J, Descamps P, Fondrinier E, Dara_ E. Fertility after conservative treatment for borderline tumours: a French multicenter study. Fertil Steril. 2005; 83:284-90.10.1016/j.fertnstert.2004.10.00915705364Open DOISearch in Google Scholar

20. Kurman RJ, Trimble CL. The behavior of serous low malignant potential: Are they ever malignant? Int J Gynecol Pathol. 1993; 12:120-7.10.1097/00004347-199304000-000068463035Open DOISearch in Google Scholar

21. Norris HJ. Proliferative endometrioid tumors and endometrioid tumors of low malignant potential of the ovary. Int J Gynecol Pathol. 1993; 12:134-40.10.1097/00004347-199304000-00008Open DOISearch in Google Scholar

22. Suh-Burgmann E. Long-term outcomes following conservative surgery for borderline tumor or the ovary: a large population- based study. Gynecol Oncol. 2006; 103:841-7.10.1016/j.ygyno.2006.05.01416793124Open DOISearch in Google Scholar

23. Trimble CL, Kosary C, Trimble EL. Long-term survival and patterns of care in women with ovarian tumors of low malignant potential. Gynecol Oncol. 2002; 86: 34-7. 10.1006/gyno.2002.671112079297Open DOISearch in Google Scholar